Anzurstobart (CC-95251, BMS-986351) is a high-affinity, fully human monoclonal anti-SIRPalpha antibody that blocks the binding of CD47 to SIRPalpha. Anzurstobart enhances macrophage phagocytic activity against DLBCL cell lines in co-culture models when combined with the antibody Rituximab.
Purity:
>98.0%
CAS Number:
[2543693-10-1]
* VAT and and shipping costs not included. Errors and price changes excepted